2,3,7,8-Tetrachlorodibenzo-p-dioxin induces transcriptional activity of the human polymorphic hs1,2 enhancer of the 3′Igh regulatory region

Journal of Immunology

Volumn 188, Issue 7, 2012, Pages 3294-3306

  Fernando, Tharu M ^a   Ochs, Sharon D ^a   Liu, Jing ^a   Chambers Turner, Ruth C ^a   Sulentic, Courtney E W ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; IMMUNOGLOBULIN HEAVY CHAIN; TRANSCRIPTION FACTOR PAX5;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENHANCER REGION; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; GENETIC POLYMORPHISM; HS1,2 GENE; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE; SENSITIVITY ANALYSIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; ENHANCER ELEMENTS, GENETIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, ARYL HYDROCARBON; RESPONSE ELEMENTS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPECIES SPECIFICITY; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC;

EID: 84859402952     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101111     Document Type: Article

References (69)

1. Lieberson, R., J. Ong, X. Shi, and L. A. Eckhardt. 1995. Immunoglobulin gene transcription ceases upon deletion of a distant enhancer. EMBO J. 14: 6229-6238.
2. Pinaud, E., A. A. Khamlichi, C. Le Morvan, M. Drouet, V. Nalesso, M. Le Bert, and M. Cogné. 2001. Localization of the 39 IgH locus elements that effect longdistance regulation of class switch recombination. Immunity 15: 187-199. (Pubitemid 32816869)
3. Vincent-Fabert, C., R. Fiancette, E. Pinaud, V. Truffinet, N. Cogné, M. Cogné, and Y. Denizot. 2010. Genomic deletion of the whole IgH 3′ regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood 116: 1895-1898.
4. Sulentic, C. E. W., M. P. Holsapple, and N. E. Kaminski. 2000. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzop- dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J. Pharmacol. Exp. Ther. 295: 705-716.
5. Sulentic, C. E. W., J. S. Kang, Y. J. Na, and N. E. Kaminski. 2004. Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3′alpha immunoglobulin heavy chain enhancer. Toxicology 200: 235-246. (Pubitemid 38798433)
6. Sulentic, C. E. W., W. Zhang, Y. J. Na, and N. E. Kaminski. 2004. 2,3,7,8- tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3′alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line. J. Pharmacol. Exp. Ther. 309: 71-78. (Pubitemid 38393116)
7. Henseler, R. A., E. J. Romer, and C. E. W. Sulentic. 2009. Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3′immunoglobulin heavy chain regulatory region. Toxicology 261: 9-18.
8. Birnbaum, L. S., and J. Tuomisto. 2000. Non-carcinogenic effects of TCDD in animals. Food Addit. Contam. 17: 275-288. (Pubitemid 30410586)
9. Sulentic, C. E. W., and N. E. Kaminski. 2011. The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo- p-dioxin. Toxicol. Sci. 120(Suppl. 1): S171-S191.
10. Swanson, H. I., and C. A. Bradfield. 1993. The AH-receptor: genetics, structure and function. Pharmacogenetics 3: 213-230. (Pubitemid 23333091)
11. Okey, A. B., M. A. Franc, I. D. Moffat, N. Tijet, P. C. Boutros, M. Korkalainen, J. Tuomisto, and R. Pohjanvirta. 2005. Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor. Toxicol. Appl. Pharmacol. 207(2, Suppl.)43-51.
12. Lai, Z. W., T. Pineau, and C. Esser. 1996. Identification of dioxin-responsive elements (DREs) in the 5′ regions of putative dioxin-inducible genes. Chem. Biol. Interact. 100: 97-112.
13. Schneider, D., M. A. Manzan, B. S. Yoo, R. B. Crawford, and N. Kaminski. 2009. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8- Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Toxicol. Sci. 108: 377-388.
14. De Abrew, K. N., N. E. Kaminski, and R. S. Thomas. 2010. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation. Toxicol. Sci. 118: 454-469.
15. Sulentic, C. E.W., M. P. Holsapple, and N. E. Kaminski. 1998. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p- dioxin of IgM secretion in activated B cells. Mol. Pharmacol. 53: 623-629. (Pubitemid 28196483)
16. Vorderstrasse, B. A., L. B. Steppan, A. E. Silverstone, and N. I. Kerkvliet. 2001. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol. Appl. Pharmacol. 171: 157-164. (Pubitemid 32217666)
17. Yoo, B. S., D. R. Boverhof, D. Shnaider, R. B. Crawford, T. R. Zacharewski, and N. E. Kaminski. 2004. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. Toxicol. Sci. 77: 272-279. (Pubitemid 38262600)
18. Schneider, D., M. A. Manzan, R. B. Crawford, W. Chen, and N. E. Kaminski. 2008. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. J. Pharmacol. Exp. Ther. 326: 463-474.
19. Wourms, M. J., and C. E. W. Sulentic. 2011. Evidence of AhR-dependent suppression of immunoglobulin expression. Toxicol. Sci. 120: 1121.
20. Salisbury, R. L., and C. E. W. Sulentic. 2011. NF-kB/Rel and the AhR in modulating the 39IghRR. Toxicol. Sci. 120: 1125.
21. Marcus, R. S., M. P. Holsapple, and N. E. Kaminski. 1998. Lipopolysaccharide activation of murine splenocytes and splenic B cells increased the expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator. J. Pharmacol. Exp. Ther. 287: 1113-1118. (Pubitemid 29131628)
22. Allan, L. L., and D. H. Sherr. 2005. Constitutive activation and environmental chemical induction of the aryl hydrocarbon receptor/transcription factor in activated human B lymphocytes. Mol. Pharmacol. 67: 1740-1750. (Pubitemid 40594175)
23. Aupetit, C., M. Drouet, E. Pinaud, Y. Denizot, J. C. Aldigier, F. Bridoux, and M. Cogné. 2000. Alleles of the alpha1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure. Kidney Int. 58: 966-971.
24. Frezza, D., V. Giambra, R. Cianci, A. Fruscalzo, M. Giufrè, G. Cammarota, C. Martìnez-Labarga, O. Rickards, G. Scibilia, C. Sferlazzas, et al. 2004. Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand. J. Gastroenterol. 39: 1083-1087. (Pubitemid 39536397)
25. Wang, J., and L. M. Boxer. 2005. Regulatory elements in the immunoglobulin heavy chain gene 39-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. J. Biol. Chem. 280: 12766-12773.
26. Frezza, D., V. Giambra, B. Tolusso, M. De Santis, S. Bosello, S. Vettori, G. Triolo, G. Valentini, and G. Ferraccioli. 2007. Polymorphism of immunoglobulin enhancer element HS1,2A: allele*2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann. Rheum. Dis. 66: 1210-1215. (Pubitemid 47309739)
27. Cianci, R., V. Giambra, C. Mattioli, M. Esposito, G. Cammarota, G. Scibilia, G. Magazzù, A. Orlando, G. Sandri, L. Bianchi, et al. 2008. Increased frequency of Ig heavy-chain HS1,2-A enhancer*2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J. Invest. Dermatol. 128: 1920-1924. (Pubitemid 352001222)
28. Tolusso, B., D. Frezza, C. Mattioli, A. L. Fedele, S. Bosello, F. Faustini, G. Peluso, V. Giambra, D. Pietrapertosa, A. Morelli, et al. 2009. Allele*2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann. Rheum. Dis. 68: 416-419.
29. Denizot, Y., E. Pinaud, C. Aupetit, C. Le Morvan, E. Magnoux, J. C. Aldigier, and M. Cogné. 2001. Polymorphism of the human alpha1 immunoglobulin gene 3′ enhancer hs1,2 and its relation to gene expression. Immunology 103: 35-40. (Pubitemid 32454522)
30. Chen, C., and B. K. Birshtein. 1997. Virtually identical enhancers containing a segment of homology to murine 3′IgH-E(hs1,2) lie downstream of human Ig C alpha 1 and C alpha 2 genes. J. Immunol. 159: 1310-1318. (Pubitemid 127484109)
31. Pinaud, E., C. Aupetit, C. Chauveau, and M. Cogné. 1997. Identification of a homolog of the C alpha 3′/hs3 enhancer and of an allelic variant of the 3′IgH/ hs1,2 enhancer downstream of the human immunoglobulin alpha 1 gene. Eur. J. Immunol. 27: 2981-2985. (Pubitemid 27478371)
32. Giambra, V., A. Fruscalzo, M. Giufre', C. Martinez-Labarga, M. Favaro, M. Rocchi, and D. Frezza. 2005. Evolution of human IgH39EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor's consensus sites. Gene 346: 105-114. (Pubitemid 40332628)
33. Frezza, D., V. Giambra, C. Mattioli, K. Piccoli, R. Massoud, A. Siracusano, M. Di Giannantonio, B. K. Birshtein, and I. A. Rubino. 2009. Allelic frequencies of 3′ Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia. Int. J. Immunopathol. Pharmacol. 22: 115-123.
34. Mills, F. C., N. Harindranath, M. Mitchell, and E. E. Max. 1997. Enhancer complexes located downstream of both human immunoglobulin Calpha genes. J. Exp. Med. 186: 845-858. (Pubitemid 27407346)
35. Kim, S. H., E. C. Henry, D. K. Kim, Y. H. Kim, K. J. Shin, M. S. Han, T. G. Lee, J. K. Kang, T. A. Gasiewicz, S. H. Ryu, and P. G. Suh. 2006. Novel compound 2- methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)- amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol. 69: 1871-1878.
36. Arnold, L. W., N. J. LoCascio, P. M. Lutz, C. A. Pennell, D. Klapper, and G. Haughton. 1983. Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity. J. Immunol. 131: 2064-2068. (Pubitemid 13007863)
37. Bishop, G. A., and G. Haughton. 1986. Induced differentiation of a transformed clone of Ly-1+ B cells by clonal T cells and antigen. Proc. Natl. Acad. Sci. USA 83: 7410-7414. (Pubitemid 16000531)
38. Williams, C. E., R. B. Crawford, M. P. Holsapple, and N. E. Kaminski. 1996. Identification of functional aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator in murine splenocytes. Biochem. Pharmacol. 52: 771-780. (Pubitemid 26276493)
39. Whitmore, A. C., D. M. Prowse, L. W. Arnold, and G. Haughton. 1989. Ig isotype switching in B lymphocytes. A method for estimating isotype switch frequency in cloned B cell lymphomas. Int. Immunol. 1: 532-539. (Pubitemid 19258087)
40. Shi, X., and L. A. Eckhardt. 2001. Deletional analyses reveal an essential role for the hs3b/hs4 IgH 3′ enhancer pair in an Ig-secreting but not an earlier-stage B cell line. Int. Immunol. 13: 1003-1012. (Pubitemid 32750503)
41. Masten, S. A., and K. T. Shiverick. 1995. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes. Biochem. Biophys. Res. Commun. 212: 27-34.
42. Romer, E. J., and C. E. W. Sulentic. 2011. Hydrogen peroxide modulates immunoglobulin expression by targeting the 3′Igh regulatory region through an NFκB-dependent mechanism. Free Radic. Res. 45: 796-809.
43. Stevens, S., J. Ong, U. Kim, L. A. Eckhardt, and R. G. Roeder. 2000. Role of OCA-B in 3′-IgH enhancer function. J. Immunol. 164: 5306-5312. (Pubitemid 30305209)
44. Ong, J., S. Stevens, R. G. Roeder, and L. A. Eckhardt. 1998. 3′ IgH enhancer elements shift synergistic interactions during B cell development. J. Immunol. 160: 4896-4903. (Pubitemid 28215324)
45. Suh, J., Y. J. Jeon, H. M. Kim, J. S. Kang, N. E. Kaminski, and K. H. Yang. 2002. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8- tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol. Appl. Pharmacol. 181: 116-123. (Pubitemid 34625942)
46. Busslinger, M., and P. Urbánek. 1995. The role of BSAP (Pax-5) in B-cell development. Curr. Opin. Genet. Dev. 5: 595-601.
47. Cobaleda, C., A. Schebesta, A. Delogu, and M. Busslinger. 2007. Pax5: the guardian of B cell identity and function. Nat. Immunol. 8: 463-470. (Pubitemid 46605911)
48. Neurath, M. F., W. Strober, and Y. Wakatsuki. 1994. The murine Ig 3′ alpha enhancer is a target site with repressor function for the B cell lineage-specific transcription factor BSAP (NF-HB, S alpha-BP). J. Immunol. 153: 730-742.
49. Neurath, M. F., E. E. Max, and W. Strober. 1995. Pax5 (BSAP) regulates the murine immunoglobulin 3′ alpha enhancer by suppressing binding of NF-alpha P, a protein that controls heavy chain transcription. Proc. Natl. Acad. Sci. USA 92: 5336-5340.
50. Michaelson, J. S., M. Singh, C. M. Snapper, W. C. Sha, D. Baltimore, and B. K. Birshtein. 1996. Regulation of 3′ IgH enhancers by a common set of factors, including kappa B-binding proteins. J. Immunol. 156: 2828-2839. (Pubitemid 126660629)
51. Linderson, Y., D. Eberhard, S. Malin, A. Johansson, M. Busslinger, and S. Pettersson. 2004. Corecruitment of the Grg4 repressor by PU.1 is critical for Pax5-mediated repression of B-cell-specific genes. EMBO Rep. 5: 291-296. (Pubitemid 38500110)
52. Barberis, A., K. Widenhorn, L. Vitelli, and M. Busslinger. 1990. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev. 4: 849-859.
53. Holmes, M. L., C. Pridans, and S. L. Nutt. 2008. The regulation of the B-cell gene expression programme by Pax5. Immunol. Cell Biol. 86: 47-53.
54. Sepulveda, M. A., A. V. Emelyanov, and B. K. Birshtein. 2004. NF-kappa B and Oct-2 synergize to activate the human 3′ Igh hs4 enhancer in B cells. J. Immunol. 172: 1054-1064. (Pubitemid 38113765)
55. Tian, Y., A. B. Rabson, and M. A. Gallo. 2002. Ah receptor and NF-kappaB interactions: mechanisms and physiological implications. Chem. Biol. Interact. 141: 97-115. (Pubitemid 35223207)
56. Tian, Y. 2009. Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochem. Pharmacol. 77: 670-680.
57. Khan, S., R. Barhoumi, R. Burghardt, S. Liu, K. Kim, and S. Safe. 2006. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/ Sp1 cross talk in breast cancer cells. Mol. Endocrinol. 20: 2199-2214. (Pubitemid 44286714)
58. Wang, F., W. Wang, and S. Safe. 1999. Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex. Biochemistry 38: 11490-11500.
59. Puga, A., S. J. Barnes, C. Chang, H. Zhu, K. P. Nephew, S. A. Khan, and H. G. Shertzer. 2000. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 59: 997-1005. (Pubitemid 30110816)
60. Hoffer, A., C. Y. Chang, and A. Puga. 1996. Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol. Appl. Pharmacol. 141: 238-247. (Pubitemid 26414370)
61. Kel, A., S. Reymann, V. Matys, P. Nettesheim, E. Wingender, and J. Borlak. 2004. A novel computational approach for the prediction of networked transcription factors of aryl hydrocarbon-receptor-regulated genes. Mol. Pharmacol. 66: 1557-1572. (Pubitemid 39564782)
62. Wood, S. C., H. G. Jeong, D. L. Morris, and M. P. Holsapple. 1993. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes. Toxicology 81: 131-143.
63. Lu, H., R. B. Crawford, J. E. Suarez-Martinez, B. L. Kaplan, and N. E. Kaminski. 2010. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8- tetrachlorodibenzo-p- dioxin in primary human B cells. Toxicol. Sci. 118: 86-97.
64. Kimata, H. 2003. 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhances spontaneous IgE production in B cells from atopic patients. Int. J. Hyg. Environ. Health 206: 601-604. (Pubitemid 37322802)
65. Guglielmi, L., V. Truffinet, E. Magnoux, M. Cogné, and Y. Denizot. 2004. The polymorphism of the locus control region lying downstream the human IgH locus is restricted to hs1,2 but not to hs3 and hs4 enhancers. Immunol. Lett. 94: 77-81. (Pubitemid 38953715)
66. Giambra, V., C. Martínez-Labarga, M. Giufré, D. Modiano, J. Simporé, B. K. Gisladottir, R. Francavilla, G. Zhelezova, S. S. Kilic, M. Crawford, et al. 2006. Immunoglobulin enhancer HS1,2 polymorphism: a new powerful anthropogenetic marker. Ann. Hum. Genet. 70: 946-950. (Pubitemid 44530656)
67. Denison, M. S., and S. R. Nagy. 2003. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43: 309-334. (Pubitemid 37372644)
68. Nguyen, L. P., and C. A. Bradfield. 2008. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21: 102-116. (Pubitemid 351219712)
69. Chauveau, C., and M. Cogné. 1996. Palindromic structure of the IgH 3′locus control region. Nat. Genet. 14: 15-16.